Allergan, Inc.
Allergan, Inc. Announces FDA Approval of JUVEDERM(R) XC Dermal Filler Formulated with Lidocaine
Published in Medical Letter on the CDC and FDA, February 21st, 2010
Allergan, Inc. (NYSE:AGN) announced the U.S. Food and Drug Administration's (FDA) approval of JUVEDERM® XC, a new formulation of the currently FDA-approved JUVEDERM® dermal filler and the latest advancement1 in hyaluronic acid (HA) dermal fillers. Allergan's new JUVEDERM® formulation contains the local anesthetic lidocaine to provide patients with enhanced comfort during treatment of moderate to severe facial wrinkles and folds, such as the nasolabial folds (or "parentheses") that appear around the nose and mouth. JUVEDERM® is the first and only hyaluronic acid dermal filler approved by the FDA to last up to one year from initial treatment2 and number-one selling...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- American Journal of Pathology
Of swine, birds and men -- pandemic H1N1 flu - Angiology
Study results from D. Calcagno and colleagues broaden understanding of angiology - Health Discovery Corporation
Vermillion Pays Health Discovery Corporation Final Patent Infringement Settlement Payment - MedImmune
Pivotal Trial Results for Motavizumab Published in Current Issue of 'Pediatrics' - Pervasis Therapeutics, Inc.
Pervasis Therapeutics Receives FDA Clearance for Pivotal Phase 3 Trial of Vascugel - Pharmaceuticals
Data on pharmaceuticals detailed by S.R. Taylor and co-authors - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
